Ranbaxy Troubles Deepen As Apotex Seeks Declaratory Judgments On Valtrex, Aricept Exclusivity; Will Nexium and Lipitor Be Next?
This article was originally published in The Pink Sheet Daily
Executive Summary
Judgment on generic valacylovir would trigger Ranbaxy's 180-day exclusivity period even though Indian firm has yet to market its product because FDA is investigating its production facilities.